Markers of Inflammation, Coagulation, and Renal Function Are Elevated in Adults with HIV Infection

Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men

Ridker, P. M., Cushman, M., Stampfer, M. J., Tracy, R. P., & Hennekens, C. H. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704033361401 · Cited by 5,504 · see citing works

C-reactive protein: a critical update

Pepys, M. B., & Hirschfield, G. M. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18921 · Cited by 4,576 · see citing works

Multi-Ethnic Study of Atherosclerosis: Objectives and Design

Bild, D. E. (2002) · American Journal of Epidemiology · doi:10.1093/aje/kwf113 · Cited by 3,942 · see citing works

CD4+ Count–Guided Interruption of Antiretroviral Treatment

The Strategies for Management of Antiretroviral Therapy (SMART) Study Group (2006) · New England Journal of Medicine · doi:10.1056/nejmoa062360 · Cited by 2,230 · see citing works

Prospective Study of C-Reactive Protein and the Risk of Future Cardiovascular Events Among Apparently Healthy Women

Ridker, P. M., Buring, J. E., Shih, J., Matias, M., & Hennekens, C. H. (1998) · Circulation · doi:10.1161/01.cir.98.8.731 · Cited by 1,642 · see citing works

. Inflammatory and coagulation biomarkers and mortality in patients with HIV infection.

Kuller, L. H., Tracy, R., Belloso, W., Wit, S. D., Drummond, F., Lane, H. C., Ledergerber, B., Lundgren, J., Neuhaus, J., Nixon, D., et al. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050203 · Cited by 1,617 · see citing works

Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly

Harris, T. B., Ferrucci, L., Tracy, R. P., Corti, M. C., Wacholder, S., Ettinger, W. H., Heimovitz, H., Cohen, H. J., & Wallace, R. (1999) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)00066-2 · Cited by 1,488 · see citing works

Cystatin C and the Risk of Death and Cardiovascular Events among Elderly Persons

Shlipak, M. G., Sarnak, M. J., Katz, R., Fried, L. F., Seliger, S. L., Newman, A. B., Siscovick, D. S., & Stehman‐Breen, C. O. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043161 · Cited by 1,241 · see citing works

Relation of C-Reactive Protein and Coronary Heart Disease in the MRFIT Nested Case-Control Study

Kuller, L. H., Tracy, R. P., Shaten, J., & Meilahn, E. N. (1996) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a008963 · Cited by 1,098 · see citing works

Variability in the measurement of C-reactive protein in healthy subjects: implications for reference intervals and epidemiological applications

Macy, E. M., Hayes, T. E., & Tracy, R. P. (1997) · Clinical Chemistry · doi:10.1093/clinchem/43.1.52 · Cited by 797 · see citing works

Long-Term Interleukin-6 Levels and Subsequent Risk of Coronary Heart Disease: Two New Prospective Studies and a Systematic Review

Danesh, J., Kaptoge, S., Mann, A. G., Sarwar, N., Wood, A., Angleman, S. B., Wensley, F., Higgins, J. P. T., Lennon, L., Eiriksdottir, G., et al. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050078 · Cited by 676 · see citing works

Fibrin D-Dimer and Coronary Heart Disease

Danesh, J., Whincup, P. H., Walker, M., LENNON, L. T., Thomson, A. G., Appleby, P. N., Rumley, A., & Lowe, G. D. O. (2001) · Circulation · doi:10.1161/01.cir.103.19.2323 · Cited by 344 · see citing works

Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients

Groups, T. S. A. T. D. S. (2008) · AIDS · doi:10.1097/qad.0b013e32830fe35e · Cited by 326 · see citing works

C-reactive protein: a critical update

Pepys, M. B., & Hirschfield, G. M. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18921c1 · Cited by 303 · see citing works

The role of HIV in serious diseases other than AIDS.

Phillips, A. N., Neaton, J., & Lundgren, J. D. (2008) · AIDS · doi:10.1097/qad.0b013e3283174636 · Cited by 269 · see citing works

Cardiovascular risk factors in young adults

Cutter, G., Burke, G. L., Dyer, A. R., FRIEDMAN, G. D., Hilner, J. E., Hughes, G. H., Hulley, S. B., Jacobs, D. R., Liu, K., Manolio, T. A., et al. (1991) · Controlled Clinical Trials · doi:10.1016/0197-2456(91)90002-4 · Cited by 261 · see citing works

Evaluation of the Dade Behring N Latex Cystatin C assay on the Dade Behring Nephelometer II System

Erlandsen, E. J., Randers, E., & Kristensen, J. H. (1999) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365519950185940 · Cited by 258 · see citing works

Immune activation and AIDS pathogenesis

Sodora, D. L., & Silvestri, G. (2008) · AIDS · doi:10.1097/qad.0b013e3282f2dbe7 · Cited by 248 · see citing works

In the Elderly, Interleukin-6 Plasma Levels and the −174G>C Polymorphism Are Associated With the Development of Cardiovascular Disease

Jenny, N. S., Tracy, R. P., Ogg, M. S., Luong, L. A., Kuller, L. H., Arnold, A. M., Sharrett, A. R., & Humphries, S. E. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000040224.49362.60 · Cited by 243 · see citing works

Inflammation, Aspirin, and the Risk of Cardiovascular Disease in Apparently Healthy Men

(1997) · New England Journal of Medicine · doi:10.1056/nejm199707313370524 · Cited by 239 · see citing works

Relative Value of Inflammatory, Hemostatic, and Rheological Factors for Incident Myocardial Infarction and Stroke

Tzoulaki, I., Murray, G. D., Lee, A. J., Rumley, A., Lowe, G. D. O., & Fowkes, F. G. R. (2007) · Circulation · doi:10.1161/circulationaha.106.635029 · Cited by 238 · see citing works

Review: Infectious Diseases and Coagulation Disorders

van Gorp, E. C. M., Suharti, C., Cate, H. T., Dolmans, W. M. V., van der Meer, J. W. M., ten Cate, J. W., & Brandjes, D. P. M. (1999) · The Journal of Infectious Diseases · doi:10.1086/314829 · Cited by 200 · see citing works

Increased Cardiovascular Disease Risk Indices in HIV-Infected Women

Dolan, S. E., Hadigan, C. M., Killilea, K. M., Sullivan, M. P., Hemphill, L., Lees, R. S., Schoenfeld, D., & Grinspoon, S. K. (2005) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/01.qai.0000159323.59250.83 · Cited by 170 · see citing works

Association of kidney function with inflammatory and procoagulant markers in a diverse cohort: A cross-sectional analysis from the Multi-Ethnic Study of Atherosclerosis (MESA)

Keller, C., Katz, R., Cushman, M., Fried, L. F., & Shlipak, M. G. (2008) · BMC Nephrology · doi:10.1186/1471-2369-9-9 · Cited by 148 · see citing works

Risk for Opportunistic Disease and Death after Reinitiating Continuous Antiretroviral Therapy in Patients with HIV Previously Receiving Episodic Therapy

The SMART Study Group* (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-149-5-200809020-00003 · Cited by 132 · see citing works

Cystatin C Level as a Marker of Kidney Function in Human Immunodeficiency Virus Infection<subtitle>The FRAM Study</subtitle>

Odden, M. C. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.20.2213 · Cited by 124 · see citing works

Association of HIV Infection and HIV/HCV Coinfection With C-Reactive Protein Levels

Reingold, J. S., WANKE, C. A., Kotler, D. P., Lewis, C. E., Tracy, R. P., Heymsfield, S. B., Tien, P. C., Bacchetti, P., Scherzer, R., Grünfeld, C., et al. (2008) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3181685727 · Cited by 107 · see citing works

Analytical and Biologic Variability in Measures of Hemostasis, Fibrinolysis, and Inflammation: Assessment and Implications for Epidemiology

Sakkinen, P. A., Macy, E. M., CALLAS, P. W., Cornell, E. S., Hayes, T. E., Kuller, L. H., & Tracy, R. P. (1999) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009801 · Cited by 97 · see citing works

Proinflammatory cytokines in HIV disease-a review and rationale for new therapeutic approaches.

Connolly, N. C., Riddler, S. A., & Rinaldo, C. R. (2005) · PubMed · Cited by 82 · see citing works

Cystatin C and Creatinine in an HIV Cohort: The Nutrition for Healthy Living Study

Jones, C. Y., Jones, C. A., Wilson, I. B., Knox, T. A., Levey, A. S., Spiegelman, D. L., Gorbach, S. L., Lente, F. V., & Stevens, L. A. (2008) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2008.01.027 · Cited by 61 · see citing works

Opportunistic Disease and Mortality in Patients Coinfected with Hepatitis B or C Virus in the Strategic Management of Antiretroviral Therapy (SMART) Study

Tedaldi, E., Peters, L., Neuhaus, J., Puoti, M., Rockstroh, J. K., Klein, M. B., Dore, G. J., Mocroft, A., Soriano, V., Clotet, B., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/593102 · Cited by 58 · see citing works

Interruption of antiretroviral therapy is associated with increased plasma cystatin C

Mocroft, A., Wyatt, C. M., Szczech, L. A. M., Neuhaus, J., El-Sadr, W. M., Tracy, R. P., Kuller, L. H., Shlipak, M. G., Angus, B., Klinker, H., et al. (2008) · AIDS · doi:10.1097/qad.0b013e32831cc129 · Cited by 51 · see citing works

Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty

Ferrucci, L., & Fabbri, E. (2018) · Nature Reviews Cardiology · doi:10.1038/s41569-018-0064-2 · Cited by 3,690 · see citing works

The end of AIDS: HIV infection as a chronic disease

Deeks, S. G., Lewin, S. R., & Havlir, D. V. (2013) · The Lancet · doi:10.1016/s0140-6736(13)61809-7 · Cited by 2,081 · see citing works

HIV Infection, Inflammation, Immunosenescence, and Aging

Deeks, S. G. (2011) · Annual Review of Medicine · doi:10.1146/annurev-med-042909-093756 · Cited by 1,349 · see citing works

Systemic Effects of Inflammation on Health during Chronic HIV Infection

Deeks, S. G., Tracy, R. P., & Douek, D. C. (2013) · Immunity · doi:10.1016/j.immuni.2013.10.001 · Cited by 871 · see citing works

National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 2

Jacobson, T. A., Maki, K. C., Orringer, C. E., Jones, P. H., Kris-Etherton, P., Sikand, G., La Forge, R., Daniels, S. R., Wilson, D. P., Morris, P. B., et al. (2015) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2015.09.002 · Cited by 784 · see citing works

Cross-sectional Comparison of the Prevalence of Age-Associated Comorbidities and Their Risk Factors Between HIV-Infected and Uninfected Individuals: The AGEhIV Cohort Study

Schouten, J., Wit, F. W. N. M., Stolte, I. G., Kootstra, N. A., van der Valk, M., Geerlings, S. E., Prins, M., Reiss, P., for the AGEhIV Cohort Study Group, Reiss, P., et al. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu701 · Cited by 755 · see citing works

Characteristics, Prevention, and Management of Cardiovascular Disease in People Living With HIV: A Scientific Statement From the American Heart Association

Feinstein, M. J., Hsue, P. Y., Benjamin, L. A., Bloomfield, G. S., Currier, J. S., Freiberg, M. S., Grinspoon, S. K., Levin, J., Longenecker, C. T., & Post, W. S. (2019) · Circulation · doi:10.1161/cir.0000000000000695 · Cited by 666 · see citing works

Soluble Markers of Inflammation and Coagulation but Not T-Cell Activation Predict Non–AIDS-Defining Morbid Events During Suppressive Antiretroviral Treatment

Tenorio, A. R., Zheng, Y., Bosch, R. J., Krishnan, S., Rodriguez, B. A., Hunt, P. W., Plants, J., Seth, A., Wilson, C. C., Deeks, S. G., et al. (2014) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiu254 · Cited by 551 · see citing works

HIV and Aging: State of Knowledge and Areas of Critical Need for Research. A Report to the NIH Office of AIDS Research by the HIV and Aging Working Group

High, K. P., Brennan-Ing, M., Clifford, D. B., Cohen, M. H., Currier, J., Deeks, S. G., Deren, S., Effros, R. B., Gebo, K., Goronzy, J. J., et al. (2012) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e31825a3668 · Cited by 522 · see citing works

Inflammation, Coagulation and Cardiovascular Disease in HIV-Infected Individuals

Duprez, D. A., Neuhaus, J., Kuller, L. H., Tracy, R. P., Belloso, W. H., Wit, S. D., Drummond, F., Lane, H. C., Ledergerber, B., Lundgren, J. D., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044454 · Cited by 520 · see citing works

Immune activation and HIV persistence: implications for curative approaches to HIV infection

Klatt, N. R., Chomont, N., Douek, D. C., & Deeks, S. G. (2013) · Immunological Reviews · doi:10.1111/imr.12065 · Cited by 439 · see citing works

HIV and Inflammation: Mechanisms and Consequences

Hunt, P. W. (2012) · Current HIV/AIDS Reports · doi:10.1007/s11904-012-0118-8 · Cited by 431 · see citing works

The effect of HAART-induced HIV suppression on circulating markers of inflammation and immune activation

Wada, N., Jacobson, L. P., Margolick, J. B., Breen, E. C., Macatangay, B. J. C., Penugonda, S., Martı́nez-Maza, O., & Bream, J. H. (2014) · AIDS · doi:10.1097/qad.0000000000000545 · Cited by 383 · see citing works

Mortality in well controlled HIV in the continuous antiretroviral therapy arms of the SMART and ESPRIT trials compared with the general population

Rodger, A. J., Lodwick, R. K., Schechter, M., Deeks, S. G., Amin, J., Gilson, R. J. C., Paredes, R., Bąkowska, E., Engsig, F. N., & Phillips, A. N. (2012) · AIDS · doi:10.1097/qad.0b013e32835cae9c · Cited by 373 · see citing works

HIV and cardiovascular disease

So‐Armah, K., Benjamin, L. A., Bloomfield, G. S., Feinstein, M. J., Hsue, P. Y., Njuguna, B., & Freiberg, M. S. (2020) · The Lancet HIV · doi:10.1016/s2352-3018(20)30036-9 · Cited by 317 · see citing works

HIV infection and stroke: current perspectives and future directions

Benjamin, L. A., Bryer, A., Emsley, H. C. A., Khoo, S., Solomon, T., & Connor, M. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70205-3 · Cited by 305 · see citing works

Altered metabolism of gut microbiota contributes to chronic immune activation in HIV-infected individuals

Vázquez-Castellanos, J. F., Villar, S. S., Latorre, A., Artacho, A., Ferrús, M. L., Madrid, N., Vallejo, A., Sainz, T., Martı́nez-Botas, J., Ferrando‐Martínez, S., et al. (2014) · Mucosal Immunology · doi:10.1038/mi.2014.107 · Cited by 303 · see citing works

HIV Infection, Immunodeficiency, Viral Replication, and the Risk of Cancer

Silverberg, M. J., Chao, C., Leyden, W. A., Xu, L., Horberg, M. A., Klein, D. B., Towner, W. J., Dubrow, R., Quesenberry, C. P., Neugebauer, R. S., et al. (2011) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-11-0777 · Cited by 293 · see citing works

Ageing and inflammation in patients with HIV infection

Nasi, M., De Biasi, S., Gibellini, L., Bianchini, E., Pecorini, S., Bacca, V, Guaraldi, G., Mussini, C., Pinti, M., & Cossarizza, A. (2016) · Clinical and Experimental Immunology · doi:10.1111/cei.12814 · Cited by 277 · see citing works

Current understanding of HIV-associated neurocognitive disorders pathogenesis

Gannon, P. J., Khan, M. Z., & Kolson, D. L. (2011) · Current Opinion in Neurology · doi:10.1097/wco.0b013e32834695fb · Cited by 269 · see citing works

Immunologic Basis of Cardiovascular Disease in HIV-Infected Adults

Hsue, P. Y., Deeks, S. G., & Hunt, P. W. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis200 · Cited by 272 · see citing works

Noncommunicable diseases among HIV-infected persons in low-income and middle-income countries

Patel, P., Rose, C. E., Collins, P. Y., Nuche‐Berenguer, B., Sahasrabuddhe, V. V., Peprah, E. K., Vorkoper, S., Pastakia, S. D., Rausch, D. M., & Levitt, N. S. (2018) · AIDS · doi:10.1097/qad.0000000000001888 · Cited by 270 · see citing works

Immunologic Biomarkers, Morbidity, and Mortality in Treated HIV Infection

Hunt, P. W., Lee, S. A., & Siedner, M. J. (2016) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiw275 · Cited by 268 · see citing works

HIV Status, Burden of Comorbid Disease, and Biomarkers of Inflammation, Altered Coagulation, and Monocyte Activation

So‐Armah, K., McGinnis, K. A., Baker, J. V., Gibert, C. L., Butt, A. A., Bryant, K. J., Goetz, M. B., Tracy, R. P., Oursler, K. K., Rimland, D., et al. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis406 · Cited by 264 · see citing works

HIV and Coronary Heart Disease

Boccara, F., Lang, S., Meuleman, C., Éderhy, S., Mary‐Krause, M., Costagliola, D. G., Capeau, J., & Cohen, A. A. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.06.063 · Cited by 261 · see citing works

HIV infection and cardiovascular disease

Hemkens, L. G., & Bucher, H. C. (2014) · European Heart Journal · doi:10.1093/eurheartj/eht528 · Cited by 251 · see citing works

Inflammation, immune activation, and cardiovascular disease in HIV

Nou, E., Lo, J., & Grinspoon, S. K. (2016) · AIDS · doi:10.1097/qad.0000000000001109 · Cited by 232 · see citing works

Inflammation, Immune Activation, and Antiretroviral Therapy in HIV

Hileman, C. O., & Funderburg, N. (2017) · Current HIV/AIDS Reports · doi:10.1007/s11904-017-0356-x · Cited by 233 · see citing works

Coronavirus 2019 and People Living With Human Immunodeficiency Virus: Outcomes for Hospitalized Patients in New York City

Sigel, K. M., Swartz, T. H., Golden, E., Paranjpe, I., Somani, S. S., Richter, F., Freitas, J. K. D., Miotto, R., Zhao, S., Polak, P. P., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa880 · Cited by 226 · see citing works

Impact of CD8+ T-cell activation on CD4+ T-cell recovery and mortality in HIV-infected Ugandans initiating antiretroviral therapy

Hunt, P. W., Cao, H. L., Muzoora, C. K., Ssewanyana, I., Bennett, J., Emenyonu, N. I., Kembabazi, A., Neilands, T. B., Bangsberg, D. R., Deeks, S. G., et al. (2011) · AIDS · doi:10.1097/qad.0b013e32834c4ac1 · Cited by 224 · see citing works

Biomarkers of immune dysfunction in HIV

Nixon, D. E., & LANDAY, A. L. (2010) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e32833ed6f4 · Cited by 223 · see citing works

Severity of Cardiovascular Disease Outcomes Among Patients With HIV Is Related to Markers of Inflammation and Coagulation

Nordell, A. D., McKenna, M. D., Borges, Á. H., Duprez, D. A., Neuhaus, J., & Neaton, J. D. (2014) · Journal of the American Heart Association · doi:10.1161/jaha.114.000844 · Cited by 220 · see citing works

Obesity and weight gain in persons with HIV

Bailin, S. S., Gabriel, C. L., Wanjalla, C. N., & Koethe, J. R. (2020) · Current HIV/AIDS Reports · doi:10.1007/s11904-020-00483-5 · Cited by 213 · see citing works

Inflammation is a major regulator of drug metabolizing enzymes and transporters: Consequences for the personalization of drug treatment

Stanke‐Labesque, F., Gautier‐Veyret, E., Chhun, S., & Guilhaumou, R. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107627 · Cited by 205 · see citing works

Does an Index Composed of Clinical Data Reflect Effects of Inflammation, Coagulation, and Monocyte Activation on Mortality Among Those Aging With HIV?

Justice, A. C., Freiberg, M. S., Tracy, R. P., Kuller, L. H., Tate, J., Goetz, M. B., Fiellin, D. A., Vanasse, G. J., Butt, A. A., Rodriguez‐Barradas, M. C., et al. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cir989 · Cited by 204 · see citing works

Gut epithelial barrier and systemic inflammation during chronic HIV infection

Somsouk, M., Estes, J. D., Deléage, C., Dunham, R. M., Albright, R. G., Inadomi, J. M., Martin, J. N., Deeks, S. G., McCune, J. M., & Hunt, P. W. (2014) · AIDS · doi:10.1097/qad.0000000000000511 · Cited by 203 · see citing works

Relevance of Interleukin-6 and D-Dimer for Serious Non-AIDS Morbidity and Death among HIV-Positive Adults on Suppressive Antiretroviral Therapy

Grund, B., Baker, J. V., Deeks, S. G., Wolfson, J. A., Wentworth, D. N., Cozzi‐Lepri, A., Cohen, C. J., Phillips, A. N., Lundgren, J. D., Neaton, J. D., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0155100 · Cited by 203 · see citing works

Time trends for risk of severe age-related diseases in individuals with and without HIV infection in Denmark: a nationwide population-based cohort study

Rasmussen, L. D., May, M., Kronborg, G., Larsen, C. S., Pedersen, C., Gerstoft, J., & Obel, N. (2015) · The Lancet HIV · doi:10.1016/s2352-3018(15)00077-6 · Cited by 201 · see citing works

An internationally generalizable risk index for mortality after one year of antiretroviral therapy

Tate, J. P., Justice, A. C., Hughes, M. D., Bonnet, F., Reiss, P., Mocroft, A., Nattermann, J., Lampe, F. C., Bucher, H. C., Sterling, T. R., et al. (2012) · AIDS · doi:10.1097/qad.0b013e32835b8c7f · Cited by 199 · see citing works

Monocytes as Regulators of Inflammation and HIV-Related Comorbidities during cART

Anzinger, J. J., Butterfield, T. R., Angelovich, T. A., Crowe, S. M., & Palmer, C. S. (2014) · Journal of Immunology Research · doi:10.1155/2014/569819 · Cited by 185 · see citing works

Multisite Comparison of High-Sensitivity Multiplex Cytokine Assays

Breen, E. C., Reynolds, S. M., Cox, C., Jacobson, L. P., Magpantay, L. I., Mulder, C. B., Dibben, O., Margolick, J. B., Bream, J. H., Sambrano, E., et al. (2011) · Clinical and Vaccine Immunology · doi:10.1128/cvi.05032-11 · Cited by 176 · see citing works

Predicting risk of cancer during HIV infection

Borges, Á. H., Silverberg, M. J., Wentworth, D. N., Grulich, A. E., Fätkenheuer, G., Mitsuyasu, R. T., Tambussi, G., Sabin, C. A., Neaton, J. D., & Lundgren, J. D. (2013) · AIDS · doi:10.1097/qad.0b013e32835f6b0c · Cited by 175 · see citing works

HIV and the Gut Microbiota: Composition, Consequences, and Avenues for Amelioration

Vujkovic-Cvijin, I., & Somsouk, M. (2019) · Current HIV/AIDS Reports · doi:10.1007/s11904-019-00441-w · Cited by 175 · see citing works

Increase in 2–Long Terminal Repeat Circles and Decrease in D-dimer After Raltegravir Intensification in Patients With Treated HIV Infection: A Randomized, Placebo-Controlled Trial

Hatano, H., Strain, M. C., Scherzer, R., Bacchetti, P., Wentworth, D. N., Hoh, R., Martin, J. N., McCune, J. M., Neaton, J. D., Tracy, R. P., et al. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit453 · Cited by 172 · see citing works

Factors Associated With Plasma IL-6 Levels During HIV Infection

Borges, Á. H., O’Connor, J. L., Phillips, A. N., Rönsholt, F. F., Pett, S. L., Vjecha, M. J., French, M. A., & Lundgren, J. D. (2015) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiv123 · Cited by 170 · see citing works

Pathophysiology of ocular surface squamous neoplasia

Gichuhi, S., Ohnuma, S., Sagoo, M. S., & Burton, M. J. (2014) · Experimental Eye Research · doi:10.1016/j.exer.2014.10.015 · Cited by 166 · see citing works

Changes in Inflammatory and Coagulation Biomarkers: A Randomized Comparison of Immediate versus Deferred Antiretroviral Therapy in Patients With HIV Infection

Baker, J. V., Neuhaus, J., Duprez, D. A., Kuller, L. H., Tracy, R. P., Belloso, W. H., Wit, S. D., Drummond, F., Lane, H. C., Ledergerber, B., et al. (2010) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3181f7f61a · Cited by 161 · see citing works

Immune activation in the course of HIV ‐1 infection: Causes, phenotypes and persistence under therapy

Younas, M., Psomas, C. K., Reynes, J., & Corbeau, P. (2015) · HIV Medicine · doi:10.1111/hiv.12310 · Cited by 159 · see citing works

Increased Risk of Myocardial Infarction in HIV-Infected Individuals in North America Compared With the General Population

Drozd, D. R., Kitahata, M. M., Althoff, K. N., Zhang, J., Gange, S. J., Napravnik, S., Burkholder, G., Mathews, W. C., Silverberg, M. J., Sterling, T. R., et al. (2017) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000001450 · Cited by 156 · see citing works

Age-related changes in CD8 T cell homeostasis and immunity to infection

Nikolich‐Žugich, J., Li, G., Uhrlaub, J. L., Renkema, K. R., & Smithey, M. J. (2012) · Seminars in Immunology · doi:10.1016/j.smim.2012.04.009 · Cited by 153 · see citing works

The CD 4: CD 8 ratio is associated with markers of age‐associated disease in virally suppressed HIV ‐infected patients with immunological recovery

Villar, S. S., Moreno, S., Fuentes, M. E., Sánchez, C., Ávila, M., Sainz, T., de Villar, N., Fernández‐Cruz, A., & Estrada, V. (2013) · HIV Medicine · doi:10.1111/hiv.12081 · Cited by 149 · see citing works

HIV infection, aging, and immune function

Dubrow, R., Silverberg, M. J., Park, L. S., Crothers, K. A., & Justice, A. C. (2012) · Current Opinion in Oncology · doi:10.1097/cco.0b013e328355e131 · Cited by 148 · see citing works

Evidence for Innate Immune System Activation in HIV Type 1–Infected Elite Controllers

Krishnan, S., Wilson, E. M. P., Sheikh, V., Rupert, A. W., Mendoza, D., Yang, J., Lempicki, R. A., Migueles, S. A., & Sereti, I. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit581 · Cited by 146 · see citing works

Probiotics Reduce Inflammation in Antiretroviral Treated, HIV-Infected Individuals: Results of the “Probio-HIV” Clinical Trial

d’Ettorre, G., Ceccarelli, G., Giustini, N., Serafino, S., Calantone, N., Girolamo, G. D., Bianchi, L., Bellelli, V., Bartoli, T. A., Marcellini, S., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0137200 · Cited by 146 · see citing works

Significance and Clinical Management of Persistent Low-Level Viremia and Very-Low-Level Viremia in HIV-1-Infected Patients

Ryscavage, P., Kelly, S. G., Li, J. Z., Harrigan, P. R., & Taiwo, B. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00076-14 · Cited by 141 · see citing works

A Plasma Biomarker Signature of Immune Activation in HIV Patients on Antiretroviral Therapy

Kamat, A., Misra, V., Cassol, E., Ancuța, P., Yan, Z., Li, C., Morgello, S., & Gabuzda, D. H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030881 · Cited by 139 · see citing works

Cardiovascular Disease Among Persons Living With HIV: New Insights Into Pathogenesis and Clinical Manifestations in a Global Context

Ntsekhe, M., & Baker, J. V. (2022) · Circulation · doi:10.1161/circulationaha.122.057443 · Cited by 143 · see citing works

Inflammation in HIV and Its Impact on Atherosclerotic Cardiovascular Disease

Obare, L. M., Temu, T. M., Mallal, S. A., & Wanjalla, C. N. (2024) · Circulation Research · doi:10.1161/circresaha.124.323891 · Cited by 147 · see citing works

Metabolic syndrome in HIV-infected individuals: underlying mechanisms and epidemiological aspects

de Paula, A. A., Falcão, M., & Pacheco, A. G. (2013) · AIDS Research and Therapy · doi:10.1186/1742-6405-10-32 · Cited by 132 · see citing works

Aging, inflammation, and HIV infection.

Aberg, J. A. (2012) · Europe PMC (PubMed Central) · Cited by 132 · see citing works

HIV cure and eradication: how will we get from the laboratory to effective clinical trials?

Lewin, S. R., & Rouzioux, C. (2011) · AIDS · doi:10.1097/qad.0b013e3283467041 · Cited by 130 · see citing works

Interleukin 6 Is a Stronger Predictor of Clinical Events Than High-Sensitivity C-Reactive Protein or D-Dimer During HIV Infection

Borges, Á. H., O’Connor, J. L., Phillips, A. N., Neaton, J. D., Grund, B., Neuhaus, J., Vjecha, M. J., Calmy, A., Koelsch, K. K., & Lundgren, J. D. (2016) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiw173 · Cited by 130 · see citing works

Changes in cardiovascular biomarkers in HIV-infected patients switching from ritonavir-boosted protease inhibitors to raltegravir

Martínez, E., d’Albuquerque, P. M., Llibre, J. M., Gutiérrez, F., Podzamczer, D., Antela, A., Berenguer, J., Domingo, P., Moreno, X. C., Pérez, I., et al. (2012) · AIDS · doi:10.1097/qad.0b013e328359f29c · Cited by 125 · see citing works

T cell activation predicts carotid artery stiffness among HIV-infected women

Kaplan, R. C., Sinclair, E., LANDAY, A. L., Lurain, N. S., Sharrett, A. R., Gange, S. J., Xue, X., Parrinello, C. M., Hunt, P. W., Deeks, S. G., et al. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.03.011 · Cited by 123 · see citing works

Vitamin D and Calcium Attenuate Bone Loss With Antiretroviral Therapy Initiation

Overton, E. T., Chan, E. S., Brown, T. T., Tebas, P., McComsey, G. A., Melbourne, K. M., Napoli, A., Hardin, W. R., Ribaudo, H. J., & Yin, M. T. (2015) · Annals of Internal Medicine · doi:10.7326/m14-1409 · Cited by 122 · see citing works

Spatiotemporal trafficking of HIV in human plasmacytoid dendritic cells defines a persistently IFN-α–producing and partially matured phenotype

O’Brien, M. P., Manches, O., Sabado, R. L., Baranda, S. J., Wang, Y., Marie, I., Rolnitzky, L. M., Markowitz, M. H., Margolis, D. M., Levy, D. E., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44960 · Cited by 121 · see citing works

Disparities in Prevalence of Key Chronic Diseases by Gender and Race/Ethnicity among Antiretroviral-Treated HIV-Infected Adults in the Us

Buchacz, K. A., Baker, R. K., Palella, F. J., Shaw, L., Patel, P., Lichtenstein, K. A., Chmiel, J. S., Vellozzi, C. J., Debes, R., Henry, K., et al. (2012) · Antiviral Therapy · doi:10.3851/imp2450 · Cited by 123 · see citing works

Premature Aging and Premature Age-Related Comorbidities in HIV-Infected Patients: Facts and Hypotheses

Capeau, J. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir628 · Cited by 119 · see citing works

Changes in Bone Turnover and Bone Loss in HIV-Infected Patients Changing Treatment to Tenofovir-Emtricitabine or Abacavir-Lamivudine

Haskelberg, H., Hoy, J., Amin, J., Ebeling, P. R., Emery, S., Carr, A. D., & STEAL Study Group (2012) · PLoS ONE · doi:10.1371/journal.pone.0038377 · Cited by 118 · see citing works

Changes in Inflammation and Immune Activation With Atazanavir-, Raltegravir-, Darunavir-Based Initial Antiviral Therapy: ACTG 5260s

Kelesidis, T., Tran, T. T. T., Stein, J. H., Brown, T. T., Moser, C., Ribaudo, H. J., Dubé, M. P., Murphy, R. L., Yang, O. O., Currier, J. S., et al. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ327 · Cited by 115 · see citing works

HIV-1–Related Cardiovascular Disease Is Associated With Chronic Inflammation, Frequent Pericardial Effusions, and Probable Myocardial Edema

Ntusi, N., O’Dwyer, E., Dorrell, L., Wainwright, E., Piechnik, S. K., Clutton, G., Hancock, G., Ferreira, V. M., Cox, P., Badri, M., et al. (2016) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.115.004430 · Cited by 110 · see citing works

HIV is associated with an increased risk of age-related clonal hematopoiesis among older adults

Dharan, N. J., Yeh, P., Bloch, M., Yeung, M. M., Baker, D., Guinto, J., Roth, N., Ftouni, S., Ognenovska, K., Smith, D., et al. (2021) · Nature Medicine · doi:10.1038/s41591-021-01357-y · Cited by 108 · see citing works

CD4+ and CD8+ T Cell Activation Are Associated with HIV DNA in Resting CD4+ T Cells

Cockerham, L. R., Siliciano, J. D., Sinclair, E., O’Doherty, U., Palmer, S., Yukl, S. A., Strain, M. C., Chomont, N., Hecht, F. M., Siliciano, R. F., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0110731 · Cited by 105 · see citing works

Immune activation and cardiovascular disease in chronic HIV infection

Longenecker, C. T., Sullivan, C., & Baker, J. V. (2015) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000227 · Cited by 108 · see citing works

Carotid Intima‐Media Thickness Progression in HIV‐Infected Adults Occurs Preferentially at the Carotid Bifurcation and Is Predicted by Inflammation

Hsue, P. Y., Scherzer, R., Hunt, P. W., Schnell, A., Bolger, A. F., Kalapus, S. C., Maka, K., Martin, J. N., Ganz, P., & Deeks, S. G. (2012) · Journal of the American Heart Association · doi:10.1161/jaha.111.000422 · Cited by 106 · see citing works

Markers of coagulation and inflammation often remain elevated in ART-treated HIV-infected patients

Funderburg, N. (2013) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000019 · Cited by 105 · see citing works

Increased Risk of Radiographic Emphysema in HIV Is Associated With Elevated Soluble CD14 and Nadir CD4

Attia, E. F., Akgün, K. M., Wongtrakool, C., Goetz, M. B., Rodriguez‐Barradas, M. C., Rimland, D., Brown, S. T., Hoo, G. W. S., Kim, J. M., Lee, P. J., et al. (2014) · CHEST Journal · doi:10.1378/chest.14-0543 · Cited by 104 · see citing works

Serious Non-AIDS Events: Therapeutic Targets of Immune Activation and Chronic Inflammation in HIV Infection

Hsu, D. C., & Sereti, I. (2016) · Drugs · doi:10.1007/s40265-016-0546-7 · Cited by 102 · see citing works

Inflammatory monocytes expressing tissue factor drive SIV and HIV coagulopathy

Schechter, M., Andrade, B. B., He, T., Richter, G. H., Tosh, K. W., Policicchio, B. B., Singh, A., Raehtz, K. D., Sheikh, V., Ma, D., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aam5441 · Cited by 103 · see citing works

Replication of CMV in the gut of HIV-infected individuals and epithelial barrier dysfunction

Maidji, E., Somsouk, M., Rivera, J. M., Hunt, P. W., & Stoddart, C. A. (2017) · PLoS Pathogens · doi:10.1371/journal.ppat.1006202 · Cited by 102 · see citing works

Prospective Antiretroviral Treatment of Asymptomatic, HIV-1 Infected Controllers

Hatano, H., Yukl, S. A., Ferre, A. L., Graf, E. H., Somsouk, M., Sinclair, E., Abdel‐Mohsen, M., Liegler, T. J., Harvill, K., Hoh, R., et al. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003691 · Cited by 101 · see citing works

CD8+ T-Cell Response to HIV Infection in the Era of Antiretroviral Therapy

Perdomo-Celis, F., Taborda, N. A., & Rugeles, M. T. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01896 · Cited by 97 · see citing works

The relationship between smoking intensity and subclinical cardiovascular injury: The Multi-Ethnic Study of Atherosclerosis (MESA)

Rifai, M. A., DeFilippis, A. P., McEvoy, J. W., Hall, M. E., Acien, A. N., Jones, M. R., Keith, R. J., Magid, H. S. A., Rodríguez, C. J., Barr, R. G., et al. (2017) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2017.01.021 · Cited by 101 · see citing works

Inflammatory and immunometabolic consequences of gut dysfunction in HIV: Parallels with IBD and implications for reservoir persistence and non-AIDS comorbidities

Alzahrani, J., Hussain, T., Simar, D., Palchaudhuri, R., Abdel‐Mohsen, M., Crowe, S. M., Mbogo, G. W., & Palmer, C. S. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.07.027 · Cited by 100 · see citing works

Pre-ART Levels of Inflammation and Coagulation Markers Are Strong Predictors of Death in a South African Cohort with Advanced HIV Disease

Ledwaba, L., Tavel, J. A., Khabo, P., Maja, P., Qin, J., Sangweni, P., Liu, X., Follmann, D. A., Metcalf, J. A., Orsega, S., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0024243 · Cited by 99 · see citing works

Plasma IL-6 levels are independently associated with atherosclerosis and mortality in HIV-infected individuals on suppressive antiretroviral therapy

Hsu, D. C., Ma, Y. F., Hur, S., Li, D., Rupert, A. W., Scherzer, R., Kalapus, S. C., Deeks, S. G., Sereti, I., & Hsue, P. Y. (2016) · AIDS · doi:10.1097/qad.0000000000001149 · Cited by 99 · see citing works

Cardiovascular Disease and Thrombosis in HIV Infection

Perkins, M. V., Joseph, S., Dittmer, D. P., & Mackman, N. (2022) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.122.318232 · Cited by 98 · see citing works

Microbiota and Probiotics in Health and HIV Infection

D’Angelo, C., Reale, M., & Costantini, E. (2017) · Nutrients · doi:10.3390/nu9060615 · Cited by 97 · see citing works

Decreases in Colonic and Systemic Inflammation in Chronic HIV Infection after IL-7 Administration

Sereti, I., Estes, J. D., Thompson, W. L., Morcock, D. R., Fischl, M. A., Croughs, T., Beq, S., de Micheaux, S. L., Yao, M. D., Ober, A., et al. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1003890 · Cited by 96 · see citing works

Analysis of biomarker data: logs, odds ratios, and receiver operating characteristic curves

Grund, B., & Sabin, C. A. (2010) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e32833ed742 · Cited by 97 · see citing works

Susceptibility to chronic inflammation: an update

Nasef, N. A., Mehta, S. Y., & Ferguson, L. R. (2017) · Archives of Toxicology · doi:10.1007/s00204-016-1914-5 · Cited by 95 · see citing works

Latent and Active Tuberculosis Infection Increase Immune Activation in Individuals Co-Infected with HIV

Sullivan, Z. A., Wong, E. B., Ndung’u, T., Kasprowicz, V. O., & Bishai, W. R. (2015) · EBioMedicine · doi:10.1016/j.ebiom.2015.03.005 · Cited by 95 · see citing works

CD4 + T Cells, Including Th17 and Cycling Subsets, Are Intact in the Gut Mucosa of HIV-1-Infected Long-Term Nonprogressors

Ciccone, E. J., Greenwald, J. H., Lee, P. I., Biancotto, A., Read, S. W., Yao, M., Hodge, J. N., Thompson, W. L., Kovacs, S. B., Chairez, C. L., et al. (2011) · Journal of Virology · doi:10.1128/jvi.02643-10 · Cited by 94 · see citing works

Immunologic predictors of coronary artery calcium progression in a contemporary HIV cohort

Baker, J. V., Hullsiek, K. H., Singh, A., Wilson, E. M. P., Henry, K., Lichtenstein, K., Önen, N. F., Kojic, E. M., Patel, P., Brooks, J. T., et al. (2013) · AIDS · doi:10.1097/qad.0000000000000145 · Cited by 93 · see citing works

Metabolic Effects of Darunavir/Ritonavir Versus Atazanavir/Ritonavir in Treatment-Naive, HIV Type 1-Infected Subjects over 48 Weeks

Aberg, J. A., Tebas, P., Overton, E. T., Gupta, S. K., Sax, P. E., LANDAY, A. L., Falcon, R., Ryan, R. J., & Rosa, G. D. L. (2012) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2011.0327 · Cited by 92 · see citing works

Atrial Fibrillation and Atrial Flutter in Human Immunodeficiency Virus-Infected Persons

Hsu, J. C., Li, Y., Marcus, G. M., Hsue, P. Y., Scherzer, R., Grünfeld, C., & Shlipak, M. G. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.03.022 · Cited by 90 · see citing works

Circulating Interleukin-6 Levels Correlate with Residual HIV Viraemia and Markers of Immune Dysfunction in Treatment-Controlled HIV-Infected Patients

Bastard, J., Soulié, C., Fellahi, S., Haïm‐Boukobza, S., Simon, A., Katlama, C., Cálvez, V., Marcelin, A., & Capeau, J. (2012) · Antiviral Therapy · doi:10.3851/imp2093 · Cited by 90 · see citing works

Inflammatory Biomarkers and Mortality Risk Among HIV-Suppressed Men: A Multisite Prospective Cohort Study

Wada, N., Bream, J. H., Martı́nez-Maza, O., Macatangay, B. J. C., Galvin, S., Margolick, J. B., & Jacobson, L. P. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw409 · Cited by 87 · see citing works

Factors Associated with D-Dimer Levels in HIV-Infected Individuals

Borges, Á. H., O’Connor, J. L., Phillips, A. N., Baker, J. V., Vjecha, M. J., Losso, M. H., Klinker, H., Lopardo, G. D., Williams, I. G., & Lundgren, J. D. (2014) · PLoS ONE · doi:10.1371/journal.pone.0090978 · Cited by 86 · see citing works

Factors contributing to risk for cancer among HIV-infected individuals, and evidence that earlier combination antiretroviral therapy will alter this risk

Borges, Á. H., Dubrow, R., & Silverberg, M. J. (2013) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000025 · Cited by 83 · see citing works

HIV Status, Burden of Comorbid Disease, and Biomarkers of Inflammation, Altered Coagulation, and Monocyte Activation

So‐Armah, K., McGinnis, K. A., Baker, J. V., Gibert, C. L., Butt, A. A., Bryant, K. J., Goetz, M. B., Tracy, R. P., Oursler, K. K., Rimland, D., et al. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis406 · Cited by 264 · see citing works

Markers of inflammation and activation of coagulation are associated with anaemia in antiretroviral-treated HIV disease

Borges, Á. H., Weitz, J. I., Collins, G., Baker, J. V., Lévy, Y., Davey, R. T., Phillips, A. N., Neaton, J. D., Lundgren, J. D., & Deeks, S. G. (2014) · AIDS · doi:10.1097/qad.0000000000000344 · Cited by 31 · see citing works

Relationship Between Inflammatory and Coagulation Biomarkers and Cardiac Autonomic Function in HIV-Infected Individuals

Young, L. C., Roediger, M. P., Grandits, G., Baker, J. V., Somboonwit, C., Williams, I. G., Lundgren, J. D., Neaton, J. D., & Soliman, E. Z. (2014) · Biomarkers in Medicine · doi:10.2217/bmm.14.27 · Cited by 12 · see citing works

Inflammation, Coagulation and Cardiovascular Disease in HIV-Infected Individuals

Duprez, D. A., Neuhaus, J., Kuller, L. H., Tracy, R. P., Belloso, W. H., Wit, S. D., Drummond, F., Lane, H. C., Ledergerber, B., Lundgren, J. D., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044454 · Cited by 520 · see citing works

Biomarkers of inflammation, coagulation and microbial translocation in HIV/HCV co-infected patients in the SMART study

Peters, L., Neuhaus, J., Duprez, D. A., Neaton, J. D., Tracy, R. P., Klein, M. B., Mocroft, A., Rockstroh, J. K., Dore, G. J., & Lundgren, J. D. (2014) · Journal of Clinical Virology · doi:10.1016/j.jcv.2014.03.017 · Cited by 27 · see citing works